Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Recent advances in genetic testing for familial hypercholesterolemia.

Expert review of molecular diagnostics - 1 Jul 2017

Iacocca Michael A, Hegele Robert A

Abstract excerpt

INTRODUCTION: Familial hypercholesterolemia (FH) is a common genetic cause of premature coronary heart disease that is widely underdiagnosed and undertreated. To improve the identification of FH and initiate timely and appropriate treatment strategies, genetic testing is becoming increasingly offered worldwide as a central part of diagnosis. Areas covered: Recent advances have been propelled by an improved...

Topics

Join the communities discussing this publication.

DNA Copy Number Variations
Genetic Predisposition to Disease
Genetic Testing
High-Throughput Nucleotide Sequencing
Hyperlipoproteinemia Type II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 28524730
DOI: 10.1080/14737159.2017.1332997

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent advances in genetic testing for familial hypercholesterolemia.PMID 28524730Read ↗

The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats.Semantic proximity Read ↗

Beyond the Usual Suspects: Expanding on Mutations and Detection for Familial Hypercholesterolemia.Semantic proximity Read ↗

Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening.Semantic proximity Read ↗

Genetic testing for familial hypercholesterolemia—past, present, and futureSemantic proximity Read ↗

Genetic testing for familial hypercholesterolemiaSemantic proximity Read ↗

Widening the spectrum of genetic testing in familial hypercholesterolaemia: Will it translate into better patient and population outcomes?Semantic proximity Read ↗

The Spectrum of Genetic Causes of Familial Hypercholesterolemia Phenotype.Semantic proximity Read ↗

Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns.Semantic proximity Read ↗

Genetic identification of familial hypercholesterolemia within a single U.S. health care systemSemantic proximity Read ↗

Genetic Testing and Risk Scores: Impact on Familial HypercholesterolemiaSemantic proximity Read ↗

Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis.Semantic proximity Read ↗

The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.